The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an ...

The U.S. House Judiciary Committee on Monday subpoenaed a former Pfizer executive after he declined to voluntarily comply with the committee's oversight into whether the company intentionally delayed ...

Pfizer’s first quarter results drew a positive market response as management emphasized margin improvement and disciplined ...

Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no commitments have been made, Chief Executive Albert Bourla said on Monday.

Pharma companies met with the Trump administration earlier this month to try and defer implementation of the executive order ...

A group of Members of the European Parliament (MEPs) claims to have gathered enough support to launch a no-confidence vote ...

The political mainstream will prevent the Commission from falling, but even a doomed no-confidence vote would refocus ...

Supporters of a motion of censure against Commission President Ursula von der Leyen hope it will put enough political ...

Far-right motion relating to pandemic scandal threatens to derail European Commission president’s second-term agenda ...

Pfizer Inc. (NYSE:PFE) is one of the best wide moat stocks to buy now. On June 9, Pfizer, along with other drug manufacturers, had a meeting with the Trump administration to talk about reducing US ...